Rhythm Pharmaceuticals Cash Flow Statement
NASDAQ: RYTMHealth CareBiotechnology: Pharmaceutical PreparationsUSD
90.78+1.14 (+1.27%)
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Rhythm Pharmaceuticals free cash flow
In fiscal 2025, Rhythm Pharmaceuticals generated -$115.7 million of operating cash flow and spent $953,000 on capital expenditures. That left free cash flow of -$116.6 million, a free-cash-flow margin of -61.5% of revenue.
Summary generated from market data by MetaCap's automated system. Methodology
Rhythm Pharmaceuticals cash flow statement (annual)
| Fiscal year (USD) | FY 20252025-12-31 | FY 20242024-12-31 | FY 20232023-12-31 | FY 20222022-12-31 | FY 20212021-12-31 | FY 20202020-12-31 | FY 20192019-12-31 | FY 20182018-12-31 | FY 20172017-12-31 | FY 20162016-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | -196.54M | -260.60M | -184.68M | -181.12M | -69.61M | -134.00M | -140.73M | -74.06M | -33.71M | -25.87M |
| Net Income growth (YoY) | — | — | — | — | — | — | — | — | — | — |
| Depreciation & Amortization | 500.00K | 700.00K | 900.00K | 896.00K | 816.00K | 690.00K | 834.00K | 442.00K | 223.00K | 144.00K |
| Stock-Based Compensation | 66.82M | 39.68M | 32.55M | 19.83M | 20.80M | 17.45M | 11.88M | 6.39M | 2.28M | 1.17M |
| Change in Working Capital | -571.00K | 2.63M | 3.15M | -12.57M | 13.71M | -5.89M | 4.13M | 667.00K | 57.00K | -48.00K |
| Operating Cash Flow | -115.67M | -113.88M | -136.16M | -173.43M | -146.00M | -121.98M | -122.75M | -62.06M | -29.46M | -23.22M |
| Capital Expenditures | -953.00K | 0 | -47.00K | -281.00K | -434.00K | -214.00K | -3.38M | -722.00K | -133.00K | -1.06M |
| Investing Cash Flow | -137.15M | -48.17M | -5.67M | 28.03M | -62.16M | 158.53M | -27.97M | -87.15M | -110.04M | -5.11M |
| Debt Issued | 0 | 0 | 24.37M | 72.34M | — | — | — | — | — | — |
| Debt Repaid | -19.92M | -12.90M | -7.40M | — | — | — | — | — | — | — |
| Financing Cash Flow | 217.96M | 191.24M | 74.37M | 213.83M | 166.48M | 2.01M | 163.47M | 164.69M | 167.20M | — |
| Net Change in Cash | -34.78M | 29.19M | -67.60M | 68.43M | -41.68M | 38.56M | 12.75M | 15.48M | 27.70M | -28.33M |
| Free Cash Flow | -116.63M | -113.88M | -136.20M | -173.71M | -146.44M | -122.19M | -126.14M | -62.78M | -29.59M | -24.28M |
This table shows 10 annual periods of Rhythm Pharmaceuticals's cash flow statement, from FY 2025 back to FY 2016, across 12 line items including net income, depreciation & amortization, stock-based compensation. Values in USD; B = billions, M = millions. Fiscal periods follow RYTM's reporting calendar. What is a cash flow statement?